The Hereditary Cancer Core provides Siteman Cancer Center members with expertise and support services to address and overcome barriers to cancer genetics research. Cancer genetics research is often difficult because of the general lack of participation from families with a history of cancer and fear of genetic research, inadequate clinical data for high-risk families, and difficulties in the recruitment of ethnically diverse populations. The Hereditary Cancer Core is organized to provide a broad range of services: . Project Management and Coordination of Study Participant Recruitment . Liaison with the Washington University School of Medicine (WUSM) Human Studies Committee . Design and Implementation of Cancer Genetics Research . Clinical Risk Assessment and Genetic Counseling . Medical Record Collection Service In addition, the core has recently launched a project referred to as the Cancer Free Controls Initiative, a St. Louis community based project to collect 2,000 blood samples with linked health and family history information from individuals 65 years of age and older who have no history of cancer. DNA and serum samples will be used in cancer case-control studies. The core is responsible for participant recruitment, specimen and data collection, and database management. Mark Watson, Director of the Tissue Procurement Core, processes the samples for genetic and protein studies. Samples will be made available to SCC investigators with approved cancer research protocols.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA091842-07
Application #
7497941
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
7
Fiscal Year
2007
Total Cost
$171,645
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Stephens, Calvin J; Kashentseva, Elena; Everett, William et al. (2018) Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9. Gene Ther 25:139-156
Trissal, Maria C; Wong, Terrence N; Yao, Juo-Chin et al. (2018) MIR142 Loss-of-Function Mutations Derepress ASH1L to Increase HOXA Gene Expression and Promote Leukemogenesis. Cancer Res 78:3510-3521
Copper, Tara Conway; Jeffe, Donna B; Ahmad, Fahd A et al. (2018) Emergency Information Forms for Children With Medical Complexity: A Qualitative Study. Pediatr Emerg Care :
McGill, Bryan E; Barve, Ruteja A; Maloney, Susan E et al. (2018) Abnormal Microglia and Enhanced Inflammation-Related Gene Transcription in Mice with Conditional Deletion of Ctcf in Camk2a-Cre-Expressing Neurons. J Neurosci 38:200-219
Sharma, Piyush K; Dmitriev, Igor P; Kashentseva, Elena A et al. (2018) Development of an adenovirus vector vaccine platform for targeting dendritic cells. Cancer Gene Ther 25:27-38
Liu, Ying; Colditz, Graham A; Rosner, Bernard A et al. (2018) Comparison of Performance Between a Short Categorized Lifestyle Exposure-based Colon Cancer Risk Prediction Tool and a Model Using Continuous Measures. Cancer Prev Res (Phila) 11:841-848
Dodson, Elizabeth A; Hipp, J Aaron; Lee, Jung Ae et al. (2018) Does Availability of Worksite Supports for Physical Activity Differ by Industry and Occupation? Am J Health Promot 32:517-526
Bauerle, Kevin T; Hutson, Irina; Scheller, Erica L et al. (2018) Glucocorticoid Receptor Signaling Is Not Required for In Vivo Adipogenesis. Endocrinology 159:2050-2061
Garbow, Joel R; Tsien, Christina I; Beeman, Scott C (2018) Preclinical MRI: Studies of the irradiated brain. J Magn Reson 292:73-81
Chiu, Ami; Hartz, Sarah; Smock, Nina et al. (2018) Most Current Smokers Desire Genetic Susceptibility Testing and Genetically-Efficacious Medication. J Neuroimmune Pharmacol 13:430-437

Showing the most recent 10 out of 1244 publications